Aryldiazonium salts as antagonists at cholinergic muscarinic receptors.
D000818:Animals; D001667:Binding, Competitive; D002217:Carbachol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003979:Diazonium Compounds / Q000378:metabolism / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008024:Ligands; D009130:Muscle, Smooth / Q000187:drug effects* / Q000378:metabolism; D010277:Parasympathomimetics / Q000037:antagonists & inhibitors; D011188:Potassium / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013997:Time Factors
D003979:Diazonium Compounds; D008024:Ligands; D010277:Parasympathomimetics; D011950:Receptors, Cholinergic; D002217:Carbachol; D011188:Potassium